Ursula Amstutz
University of Bern(CH)University Hospital of Bern(CH)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Pharmacogenetics and Drug Metabolism, Epigenetics and DNA Methylation, Pancreatic and Hepatic Oncology Research, Prostate Cancer Treatment and Research
Most-Cited Works
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update(2017)633 cited
- → Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data(2015)368 cited
- → A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer(2015)270 cited
- → Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity(2016)230 cited
- → Dihydropyrimidine Dehydrogenase Gene as a Major Predictor of Severe 5-Fluorouracil Toxicity(2011)212 cited
- → Recommendations for HLA‐B*15:02 and HLA‐A*31:01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions(2014)203 cited